8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a DPP inhibitor

Details for Australian Patent Application No. 2012202850 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Himmelsbach, Frank; Langkopf, Elke; Eckhardt, Matthias; Tadayyon, Mohammad; Thomas, Leo

Agent Davies Collison Cave

Pub. Number AU-A-2012202850

Parent 2005219508

Filing date 16 May 2012

Wipo publication date 7 June 2012

International Classifications

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

31 May 2012 Complete Application Filed

7 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202850

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202851-Sewer vent

2012202849-Bag